Jane Street’s Immunic IMUX Stock Holding History

Jane Street’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$147K	Buy	+13,250	New	+$119K	﹤0.01%	10403

Other funds holding IMUX

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Jane Street's IMUX Position: Q1 2026 in Review

Jane Street increased its Immunic (IMUX) stake by 130% in Q1 2026, buying an estimated $334K and bringing the position to 65,915 shares worth $732K. The position accounts for ﹤0.01% of the portfolio, ranked #7176.

Jane Street first reported a position in IMUX in Q2 2014 and has held it in 23 quarters since. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

Jane Street held 65,915 shares of Immunic worth $732K as of Q1 2026.
Jane Street bought 37,247 Immunic shares in Q1 2026, an estimated $334K.
Immunic made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7176 holding.
Jane Street first reported a position in Immunic in Q2 2014 and has held it in 23 quarters since.
75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.